Home » Topics » Regulatory

Regulatory
RSS

Japan Tobacco and Torii gain approval for Riona Tablets in Japan

Jan. 17, 2014

FDA approves Isentress pediatric oral suspension

Jan. 10, 2014

FDA approves Orenitram for PAH

Dec. 24, 2013

FDA approves Sovaldi for chronic hepatitis C

Dec. 9, 2013

FDA approves Xiaflex for Peyronie's disease

Dec. 9, 2013

Daiichi Sankyo launches new formulation of natural tetrahydrobiopterin agent

Dec. 2, 2013

FDA approves Varithena for the treatment of patients with incompetent veins

Nov. 28, 2013

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

FDA approves Nexavar for thyroid cancer

Nov. 25, 2013

Onoact 50 approved in Japan for new indication

Nov. 22, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 21, 2025.
Neurobiogen divulges new MAO-B inhibitors for Parkinson’s disease
BioWorld Science
Neurobiogen Co Ltd. has synthesized monoamine oxidase-B (MAO-B) inhibitors reported to be useful for the treatment of Parkinson’s disease.
Scorpion Therapeutics patents p53 Y220 mutant activators
BioWorld Science
Work at Scorpion Therapeutics Inc. has led to the identification of cellular tumor antigen p53 (TP53) (Y220C mutant) activators reported to be useful for the...
Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody
BioWorld
Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...